News

New Limited Edition SEKKISEI Lotion Promotes Coral Reef Protection

New Limited Edition SEKKISEI Lotion Promotes Coral Reef Protection

Launch of Limited Edition SAVE THE BLUE Lotion

SEKKISEI, a renowned skincare brand, continues its impactful Save the Blue initiative with a new Limited Edition SAVE THE BLUE Lotion. This innovative product is aimed at raising awareness and funds for the pressing need to conserve our marine ecosystems, particularly coral reefs.

Support for Coral Reef Alliance

The brand is honored to renew its commitment to ocean conservation by partnering with the Coral Reef Alliance (CORAL) for the seventh consecutive year. CORAL is an esteemed nonprofit organization dedicated to protecting coral reef systems and the diverse ocean life that thrives within them. Through a comprehensive, science-based strategy, CORAL tackles pressing challenges such as unsustainable fishing practices, water quality degradation, and the detrimental effects of climate change, all while ensuring that coral reefs can flourish rather than merely endure.

Details of the Campaign

As part of its commitment during July, SEKKISEI will donate $1 from each sale of the Limited Edition SAVE THE BLUE Lotion sold via its online store. Priced at $88 for 16.9 fl oz (500 mL), the proceeds will directly support the ongoing efforts of CORAL across North America and the Caribbean. This lotion is a beloved staple in the J-Beauty world, known for its ultra-hydrating properties. Lightweight yet nutrient-rich, it enhances the skin's ability to absorb other treatments, delivering a radiant glow with each application. Users can enjoy it as a conventional moisturizer during their skincare routine or apply it as a hydrating mask for an instant refresh.

Impact of the Save the Blue Initiative

Since its inception, the Save the Blue initiative has achieved remarkable milestones, including the planting of over 20,000 coral polyps worldwide. Its outreach efforts have successfully expanded to eight different countries, restoring more than 122 million cm² of vital reef habitat. These contributions help foster a more resilient ocean that future generations can cherish.

About SEKKISEI

SEKKISEI has been a trusted name in the skincare industry since its establishment in 1985. The brand has consistently set benchmarks in hydration, skin clarity, and balanced complexion through a unique combination of ancient Asian herbal wisdom and advanced Japanese scientific techniques. SEKKISEI's formulations are enriched with expertly selected botanicals sourced from numerous herbs, providing deep hydration and luminosity for healthier-looking skin.

Frequently Asked Questions

What is the SAVE THE BLUE initiative?

The SAVE THE BLUE initiative is SEKKISEI's effort to promote ocean conservation and protect coral reefs worldwide by supporting projects that enhance marine ecosystems.

How can I support the SAVE THE BLUE campaign?

You can support the campaign by purchasing the Limited Edition SAVE THE BLUE Lotion, with $1 from each sale contributing to coral reef protection efforts.

What is the price of the Limited Edition SAVE THE BLUE Lotion?

The Limited Edition SAVE THE BLUE Lotion is priced at $88 for a 16.9 fl oz (500 mL) bottle.

How does SEKKISEI contribute to coral reef conservation?

SEKKISEI partners with organizations like the Coral Reef Alliance to fund and support initiatives that address coral health and sustainability issues.

Where can I find more information about SEKKISEI products?

More information about SEKKISEI's product offerings, including the SAVE THE BLUE Lotion, can be found on their official U.S. e-commerce site.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Microfluidics Market Growth: Insights and Future Trends

Updated Category News Views 112

Microfluidics Market Overview The global microfluidics market, valued at approximately USD 21.36 billion, is set for impressive growth. Predictions suggest it will reach about USD 32.67 billion by the end of 2029. This significant expansion is a clear indicator of the transformation occurring within diagnostics, life sciences, and pharmaceutical research. Driving Forces...

Continue Reading
How a $1000 Investment in Primerica Can Grow Over Time

Updated Category News Views 333

The Incredible Growth of Primerica Primerica (NYSE: PRI) has truly left a mark in the financial sector, showcasing remarkable performance over the last decade. With an annualized return of 17.97%, it has outperformed the market by 7.08%, demonstrating its strong foundational growth and investment appeal. As of now, Primerica holds a market capitalization of $9.18 billion,...

Continue Reading
Illumina Joins Forces with MyOme: A Game Changer in Healthcare

Updated Category News Views 115

Illumina and MyOme Collaboration Overview Illumina has recently entered into a significant collaboration deal with MyOme, a company specializing in genomic analysis. This partnership isn't just a strategic investment; it's an aerospace-like synergy aimed at transforming how healthcare operates in the United States. With a bold vision, the duo is set to explore innovative...

Continue Reading
BlackSky Technology Secures Major Contract Boosting Stock Appeal

Updated Category News Views 117

BlackSky Technology Gains Momentum After Major Contract Win BlackSky Technology Inc (BKSY) has seen its shares trade higher recently thanks to the remarkable announcement of a five-year contract with the U.S. National Geospatial-Intelligence Agency (NGA). This contract, valued at up to $290 million, will enable BlackSky to leverage its advanced satellite monitoring...

Continue Reading
BioXcel Therapeutics to Showcase Innovations at Conference

Updated Category News Views 255

BioXcel Therapeutics: AI in Medicine BioXcel Therapeutics, Inc. (NASDAQ: BTAI) is making waves in the biopharmaceutical sector using artificial intelligence (AI) to forge new paths in neuroscience medication. The CEO, Vimal Mehta, Ph.D., will take the stage at the highly regarded Canaccord Genuity 45th Annual Growth Conference. This pivotal event will take place in...

Continue Reading